Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Liabilities and Shareholders Equity (2016 - 2025)

Innovate (VATE) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $868.0 million in Q1 2025.

  • For Q1 2025, Liabilities and Shareholders Equity fell 8.0% year-over-year to $868.0 million; the TTM value through Sep 2025 reached $868.0 million, down 77.06%, while the annual FY2023 figure was $1.0 billion, 9.39% down from the prior year.
  • Liabilities and Shareholders Equity reached $868.0 million in Q1 2025 per VATE's latest filing, down from $897.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.9 billion in Q2 2021 and bottomed at $868.0 million in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $2.0 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: plummeted 83.93% in 2021, then rose 6.58% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.1 billion in 2021, then increased by 6.58% to $1.2 billion in 2022, then decreased by 9.39% to $1.0 billion in 2023, then decreased by 14.03% to $897.2 million in 2024, then dropped by 3.25% to $868.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $868.0 million in Q1 2025, $897.2 million in Q3 2024, and $898.9 million in Q2 2024.